Dormant
ACDC · ProFrac Holding Corp.
Last analysed ·
Current thesis
ProFrac's frac-pricing recovery has September financing relief, but operating confirmation is missing. The case requires Q3 stimulation margin above the 9% reported on 2026-08-06 and a weekly close above the August reference of $5.37 before a weekly close below $4.90.
Kill line
A weekly close below $4.90 invalidates the recovery structure at the historical 2026-07-09 reference; Q3 Stimulation Services adjusted EBITDA margin at or below Q2's 9% would also reject the operating improvement case.
Pick status
Open commitment catalyst in 3dscored if the kill line above fires How this is scored →Latest analysis and events for ACDC —
As of 19 September 2026, the latest FrontierPicks analysis for ProFrac Holding Corp. (ACDC): 5 June 2026: ACDC −10.1%, WTI $91.40 (−1.76%), Brent <$90; trigger = US President 'talks progressing well' + Iran Strait-reopening signal + 10-day Israel-Lebanon ceasefire + hot jobs print (rate-up = bad for levered E&P).
Kill line: A weekly close below $4.90 invalidates the recovery structure at the historical 2026-07-09 reference; Q3 Stimulation Services adjusted EBITDA margin at or below Q2's 9% would also reject the operating improvement case.
Next dated event on file: — catalyst in 3d.
Current Thesis
ProFrac's frac-pricing recovery requires stronger third-quarter margins and a recovery above its August market reference; September financing relief has improved the debt-payment schedule without establishing an operating recovery. The measurable case is a Q3 Stimulation Services adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) margin above the 9% reported on 2026-08-06, alongside a weekly close above the market's 2026-08-14 close of $5.37, before a weekly close below $4.90.
The material development since the September coverage is a 2026-09-11 transaction cancelling $60 million of term loans in exchange for 2,306,806 Flotek shares transferred to affiliated lenders. ProFrac disclosed the transaction on 2026-09-16. This is financing relief, with an asset transferred in return. ProFrac Form 8-K.
As an inference, the narrative is maturing — the pricing improvement discussed on 2026-08-06 remains unconfirmed by another quarterly report, while the adjusted close of $5.17 on 2026-09-18 remains below the August reference of $5.37. The latest close updates the market evidence; it does not establish whether the operating recovery has arrived.
Bullish and bearish views on ProFrac Holding Corp.
The model's bull view on ProFrac Holding Corp. (ACDC), in brief: Scheduled payments have been deferred. The amendment dated 2026-09-11 reduces quarterly amortization from $15 million to zero through 2028-03-31 and extends the loan maturity to 2030-02-15. These contractual changes reduce scheduled near-term cash payments. September 16 filing.… The bear view: Deferral carries continuing financing constraints. Both cases follow in full.
Bull Case
- Scheduled payments have been deferred. The amendment dated 2026-09-11 reduces quarterly amortization from $15 million to zero through 2028-03-31 and extends the loan maturity to 2030-02-15. These contractual changes reduce scheduled near-term cash payments. September 16 filing.
- The operating comparison had improved. ProFrac's 2026-08-06 Q2 release reported revenue of $498.1 million, up 11% sequentially, and adjusted EBITDA of $69.4 million at a 14% margin. Those are historical results, not evidence that Q3 has already improved.
- Management identified a specific mechanism. On the 2026-08-06 call, management attributed expected Q3 stimulation improvement to pricing increases and steady utilization. A Q3 segment margin at or below the reported Q2 margin of 9% would reject the margin-expansion interpretation of that guidance.
Bear Case
- Deferral carries continuing financing constraints. The 2026-09-11 amendment permits interest capitalization and requires a quarterly sweep of 100% of excess cash flow. The former can increase principal; the latter restricts retained cash. September 16 filing.
- Current liquidity remains unquantified here. The 2026-08-06 results reported approximately $72 million of liquidity at 2026-06-30. An updated liquidity figure following the September transaction is missing; the historical amount cannot establish present capacity.
- The market has not confirmed recovery. The supplied adjusted-price record shows ACDC down 15.4% over three months and 35.9% below its $8.06 trailing-year high as of 2026-09-18. The $5.17 close remains below the 2026-08-14 reference close of $5.37 despite the financing announcement.
Setup & Price Structure
The measured 2026-09-18 close is $5.17, compared with $5.15 on 2026-09-04 in the prior public price record. The latest 14-day relative strength index is 55.2. Neither observation establishes expanding participation because corresponding turnover and moving-average measurements are missing.
The market's $5.37 close on 2026-08-14 remains the recovery reference, while $4.90, associated with 2026-07-09 in the historical record, remains the downside thesis boundary. A weekly close above $5.37 would satisfy the price component of the case; a weekly close below $4.90 would invalidate it. These are research conditions, not forecasts that either level must trade.
The dated ownership evidence consists of THRC purchases reported for 2026-08-10 and 2026-08-11 in the supplied Form 4 record. That establishes participation by an existing control-group affiliate at those dates. Current retail-coverage clustering, short interest and fund-flow measurements are missing, so the evidence does not support a crowding verdict.
Catalyst Calendar (next 30 days)
- 2026-09-23 — US petroleum inventory report. The US Energy Information Administration (EIA) identifies this as its next Weekly Petroleum Status Report release. Inventory changes test the oil-supply backdrop; they do not measure ProFrac's completion pricing. EIA release page.
- 2026-09-30 and 2026-10-07 — Scheduled inventory updates. These follow the EIA's published Wednesday schedule and provide subsequent observations of the same commodity backdrop. EIA release schedule.
- 2026-10-15 — Holiday-adjusted inventory release. The EIA explicitly schedules this release for Thursday. It remains an indirect macro catalyst rather than a company earnings test. EIA holiday schedule.
As checked on 2026-09-20, ProFrac's investor calendar lists no upcoming events. A company-confirmed Q3 reporting date is therefore unavailable; the earlier November estimate is not treated as a scheduled event. ProFrac investor calendar.
What Would Change Our Mind
Loss of the historical lower reference would end the recovery structure: a weekly close below $4.90 breaches the level associated with 2026-07-09. The operating case would also fail if Q3 Stimulation Services adjusted EBITDA margin does not exceed the 9% reported for Q2 on 2026-08-06.
Conversely, a weekly close above the 2026-08-14 reference of $5.37 together with a Q3 segment margin above 9%, before the downside condition occurs, would satisfy the published recovery case. The September financing transaction alone does not meet those tests.
Correlation Notes
This remains a single-name operating and financing case. The supplied September coverage paired elevated Brent observations on 2026-08-21 and 2026-09-04 with weak equity responses. The sample is too small to support a claim that ACDC's relationship with crude has permanently broken.
The EIA's 2026-09-16 report recorded commercial crude inventories of 423.4 million barrels for the week ending 2026-09-11, down 0.6 million barrels and 1% above the five-year average. That measures the commodity backdrop, not demand for ProFrac's services; the company's Q3 pricing and margin disclosures remain the direct tests. EIA Weekly Petroleum Status Report.
Notes
- 2026-06-05: ACDC −10.1%, WTI $91.40 (−1.76%), Brent <$90; trigger = US President 'talks progressing well' + Iran Strait-reopening signal + 10-day Israel-Lebanon ceasefire + hot jobs print (rate-up = bad for levered E&P).
- Wilks-family controlled; Matt Wilks has held both Executive Chairman and CEO roles since 2026-08-07, leaving minority holders limited governance influence.
- Consolidates a majority stake in Flotek Industries (NYSE: FTK); Flotek segment revenue and margin flow through ACDC's reported P&L.
- An oilfield-services operator, not an E&P: no production hedges, and revenue comes from completion activity and frac pricing rather than the barrel.
- Liquidity was about $72M at 2026-06-30 against roughly $1.10B principal debt — balance-sheet capacity is a standing constraint in any soft quarter.
- The ticker is an AC/DC pun and is frequently confused in retail chatter with unrelated names; verify the ticker before sourcing sentiment data.
- Class A float is small relative to Wilks-controlled holdings: 87,500,195 Class A shares held indirectly through THRC after the August purchases.
Related · shared themes
OSCR
Oscar Health, Inc.
Oscar Health's higher earnings outlook and quantified 2027 pricing support a post-Investor-Day rerating. A weekly close above $32.76 before a weekly close below $29.83 would complete the price-confirmation test; the September 18, 2026 close of $32.13 leaves it unresolved.
CNC
Centene Corporation
Centene's margin-repair case requires sustained earnings guidance and a weekly close above $68.72 by its 2026-10-27 results. September's reaffirmation supports the earnings leg, but a weekly close below $65 or withdrawal or reduction of fiscal 2026 adjusted EPS guidance above $4.80 invalidates the case.
HNGE
Hinge Health, Inc.
Digital-MSK profitability re-rate broke out in May and was pushed into open price discovery by the 2026-06-09 mid-quarter raise (Q2 to $200–202M, +45%; FY26 to $818–824M). But nine sell-side target hikes in two weeks plus accelerating insider selling mark a late, distribution-prone phase, with no company catalyst until the ~2026-08-04 Q2 print.
HUM
Humana Inc.
Humana's Medicare Advantage margin-recovery story faces a renewed price test: an adjusted daily close above $409.80 before a daily close below $383. The September 1, 2026 earnings reaffirmation supports stability, while October Star Ratings test the quality-bonus premise.
See also · stocks to watch